• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Expression of epidermal growth factor receptor detected by cetuximab indicates its efficacy to inhibit in vitro and in vivo proliferation of colorectal cancer cells

Research Project

Project/Area Number 23791559
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Digestive surgery
Research InstitutionKeio University

Principal Investigator

SHIGETA Kohei  慶應義塾大学, 医学部, 助教 (30528790)

Project Period (FY) 2011 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywords大腸癌 / 分子標的治療薬 / セツキシマブ
Research Abstract

Cetuximab is a monoclonal antibody of the IgG1 subclass that targets the human epidermal growth factor receptor (EGFR). We hypothesized that the expression levels of EGFR which can be detected by cetuximab itself may influence the inhibition of cell proli

Report

(3 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Research-status Report
  • Research Products

    (8 results)

All 2013 2012 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (6 results)

  • [Journal Article] Expression of epidermal growth factor receptor detected by cetuximab indicates its efficacy to inhibit in vitro and in vivo proliferation of colorectal cancer cells2013

    • Author(s)
      Kohei Shigeta, Tetsu Hayashida, Yoshinori Hoshino, Koji Okabayashi, Takashi Endo, Yoshiyuki Ishii, Hirotoshi Hasegawa, Yuko Kitagawa
    • Journal Title

      PLOS ONE

      Volume: 8(6) Issue: 6 Pages: e66302-e66302

    • DOI

      10.1371/journal.pone.0066302

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Expression of epidermal growth factor receptor detected by cetuximab indicates its efficacy to inhibit in vitro and in vivo proliferation of colorectal cancer cells2013

    • Author(s)
      Kohei Shigeta
    • Journal Title

      PLOS ONE

      Volume: 不明

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Presentation] Expression of EGFR on membrane surface detected by cetuximab itself contributes to the efficacy of cetuximab in colorectal cancer cell2013

    • Author(s)
      Kohei Shigeta
    • Organizer
      AACR/JCA joint conference 2013
    • Place of Presentation
      Maui, Hawaii
    • Year and Date
      2013-02-24
    • Related Report
      2012 Final Research Report
  • [Presentation] 大腸癌細胞膜表面EGFR の発現量とCetuximab感受性2012

    • Author(s)
      茂田 浩平
    • Organizer
      日本癌学会総会2012
    • Place of Presentation
      札幌 ポスター
    • Year and Date
      2012-09-20
    • Related Report
      2012 Final Research Report
  • [Presentation] 大腸癌細胞膜表面EGFRとCetuximab感受性の相関2012

    • Author(s)
      茂田 浩平
    • Organizer
      日本癌転移学会総会2012
    • Place of Presentation
      広島ワークショップ6-3
    • Year and Date
      2012-07-13
    • Related Report
      2012 Final Research Report
  • [Presentation] 大腸癌細胞膜表面EGFRとCetuximab感受性の相関

    • Author(s)
      茂田 浩平
    • Organizer
      日本がん転移学会
    • Place of Presentation
      広島 ワークショップ6-3
    • Related Report
      2012 Annual Research Report
  • [Presentation] 大腸癌細胞膜表面EGFRの発現量とCetuximab感受性

    • Author(s)
      茂田 浩平
    • Organizer
      日本癌学会
    • Place of Presentation
      札幌 ポスター
    • Related Report
      2012 Annual Research Report
  • [Presentation] セツキシマブにより検出されたEGFR発現量と薬剤感受性の相関の検討

    • Author(s)
      茂田 浩平
    • Organizer
      日本消化器外科学会
    • Place of Presentation
      宮崎 企画関連口演 消化器癌個別化治療 6
    • Related Report
      2012 Annual Research Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi